111 filings
Page 5 of 6
8-K
go5iaddx
22 Sep 20
Adial Pharmaceuticals and iRemedy Partner to Sell COVID-19 Antibody Test Kits to U.S. Medical Providers and Commence Sales
9:31am
8-K
1dwsvgc50 b0
22 Sep 20
Unregistered Sales of Equity Securities
12:00am
8-K
zgsxep49c8g20o27 rfe
18 Sep 20
Other Events
9:34am
8-K
oqa24rc0bg ndt
2 Sep 20
Departure of Directors or Certain Officers
6:17am
8-K
gmrg0
25 Aug 20
Entry into a Material Definitive Agreement
8:08am
8-K
255z64qlroqyj 7nzrq6
6 Aug 20
Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits
10:04am
8-K
7rt79ir1 3c1znl5
31 Jul 20
Other Events
8:38am
8-K
mjevypk8
21 Jul 20
Other Events
9:06am
8-K
4a1mckkh7 8w6c
12 Jun 20
Other Events
12:00am
8-K
m8rtuadn6ftmytl240
11 Jun 20
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland
11:58am
8-K
at7p1ch4
10 Jun 20
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
4:05pm
8-K
es43xed52spz0t n3zi
8 Jun 20
Adial Pharmaceuticals and BioLab Sciences Enter into Distribution Agreement
9:40am
8-K
y4w6e
27 May 20
Other Events
11:05am
8-K
kiomtbqcy6n3lvzfk7u
20 May 20
Departure of Directors or Certain Officers
3:15pm
8-K
m023z 1ydj
6 Mar 20
Departure of Directors or Certain Officers
6:03am
8-K
m5klzmwh 3hw4pm
6 Feb 20
Other Events
5:10pm
8-K
mpf8h7 cpm3
31 Dec 19
Entry into a Material Definitive Agreement
4:04pm
8-K
dv716
16 Dec 19
Entry into a Material Definitive Agreement
6:02am
8-K
zdb8zc9s 070ar
4 Oct 19
Departure of Directors or Certain Officers
5:25pm
8-K
khoc48h 1ib3b
20 Aug 19
Submission of Matters to a Vote of Security Holders
4:10pm